Fcγ receptor-mediated inflammation inhibits axon regeneration

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Zhang, Gang ^a   Bogdanova, Nataliia ^a   Gao, Tong ^a   Song, Julia J ^a   Cragg, Mark S ^b   Glennie, Martin J ^b   Sheikh, Kazim A ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; FC RECEPTOR; GANGLIOSIDE ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY MEDIATED INHIBITION; ARTICLE; CELL POPULATION; CELL SURFACE; COMPLEX FORMATION; CONTROLLED STUDY; ELECTROPHYSIOLOGY; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGE; MALE; MICROGLIA; MORPHOMETRICS; MOUSE; MOUSE MUTANT; NERVE FIBER REGENERATION; NONHUMAN; PINPRICK TEST; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SCIATIC NERVE INJURY; TRANSGENIC MOUSE; UPREGULATION; WESTERN BLOTTING; WILD TYPE;

ANIMALS; AUTOANTIBODIES; AXONS; BEHAVIOR, ANIMAL; COMPLEMENT ACTIVATION; DISEASE MODELS, ANIMAL; GANGLIOSIDES; GUILLAIN-BARRE SYNDROME; INFLAMMATION; MACROPHAGES; MALE; MICE; MICE, TRANSGENIC; MUTATION; NERVE REGENERATION; PERIPHERAL NERVES; RECEPTORS, IGG; SCIATIC NERVE;

EID: 84895532663     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088703     Document Type: Article

References (51)

1. Willison HJ, Yuki N (2002) Peripheral neuropathies and anti-glycolipid antibodies. Brain 125: 2591-2625. (Pubitemid 35423511)
2. Hughes RA, Cornblath DR (2005) Guillain-Barre syndrome. Lancet 366: 1653-1666.
3. Sheikh KA, Ho TW, Nachamkin I, Li CY, Cornblath DR, et al. (1998) Molecular mimicry in Guillain-Barre syndrome. Ann N Y Acad Sci 845:307-21: 307-321.
4. Yuki N, Yamada M, Sato S, Ohama E, Kawase Y, et al. (1993) Association of IgG anti-GD1a antibody with severe Guillain-Barre syndrome. Muscle Nerve 16: 642-647. (Pubitemid 23157336)
5. Kuwabara S, Asahina M, Koga M, Mori M, Yuki N, et al. (1998) Two patterns of clinical recovery in Guillain-Barre syndrome with IgG anti-GM1 antibody. Neurology 51: 1656-1660.
6. Press R, Mata S, Lolli F, Zhu J, Andersson T, et al. (2001) Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barre syndrome. J Neurol Sci 190: 41-47. (Pubitemid 33713020)
7. Hadden RD, Karch H, Hartung HP, Zielasek J, Weissbrich B, et al. (2001) Preceding infections, immune factors, and outcome in Guillain-Barre syndrome. Neurology 56: 758-765. (Pubitemid 32240096)
8. Koga M, Yuki N, Hirata K, Morimatsu M, Mori M, et al. (2003) Anti-GM1 antibody IgG subclass: a clinical recovery predictor in Guillain-Barre syndrome. Neurology 60: 1514-1518. (Pubitemid 36554815)
9. Carpo M, Pedotti R, Allaria S, Lolli F, Mata S, et al. (1999) Clinical presentation and outcome of Guillain-Barre and related syndromes in relation to anti-ganglioside antibodies. J Neurol Sci 168: 78-84. (Pubitemid 29467423)
10. Kaida K, Morita D, Kanzaki M, Kamakura K, Motoyoshi K, et al. (2007) Anti-ganglioside complex antibodies associated with severe disability in GBS. J Neuroimmunol 182: 212-218. (Pubitemid 46026709)
11. Kuwabara S, Yuki N, Koga M, Hattori T, Matsuura D, et al. (1998) IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barre syndrome. Ann Neurol 44: 202-208. (Pubitemid 28374108)
12. Yuki N, Yoshino H, Sato S, Shinozawa K, Miyatake T (1992) Severe acute axonal form of Guillain-Barre syndrome associated with IgG anti-GD1a antibodies. Muscle Nerve 15: 899-903.
13. Sheikh KA, Zhang G (2010) An update on pathobiologic roles of anti-glycan antibodies in Guillain-Barré syndrome. F1000 Biology Reports 2: 21.
14. Lehmann HC, Lopez PHH, Zhang G, Ngyuen T, Zhang JY, et al. (2007) Passive immunization with anti-ganglioside antibodies directly inhibits axon regeneration in an animal model. J Neurosci 27: 27-34. (Pubitemid 46089956)
15. Lopez PH, Zhang G, Zhang J, Lehmann HC, Griffin JW, et al. (2010) Passive Transfer of IgG Anti-GM1 Antibodies Impairs Peripheral Nerve Repair. J Neurosci 30: 9533-9541.
16. Nimmerjahn F, Ravetch JV (2008) Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 8: 34-47.
17. Nimmerjahn F, Ravetch JV (2011) FcgammaRs in health and disease. Curr Top Microbiol Immunol 350: 105-125.
18. Su K, Wu J, Edberg JC, Li X, Ferguson P, et al. (2004) A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcgammaRIIb alters receptor expression and associates with autoimmunity. I. Regulatory FCGR2B polymorphisms and their association with systemic lupus erythematosus. J Immunol 172: 7186-7191. (Pubitemid 38669163)
19. Collins FS, Rossant J, Wurst W (2007) A mouse for all reasons. Cell 128: 9-13.
20. Lunn MP, Johnson LA, Fromholt SE, Itonori S, Huang J, et al. (2000) High-affinity anti-ganglioside IgG antibodies raised in complex ganglioside knockout mice: reexamination of GD1a immunolocalization. J Neurochem 75: 404-412. (Pubitemid 30418208)
21. Lopez PH, Zhang G, Bianchet MA, Schnaar RL, Sheikh KA (2008) Structural requirements of anti-GD1a antibodies determine their target specificity. Brain 131: 1926-1939. (Pubitemid 351957448)
22. Ma CH, Omura T, Cobos EJ, Latremoliere A, Ghasemlou N, et al. (2011) Accelerating axonal growth promotes motor recovery after peripheral nerve injury in mice. J Clin Invest 121: 4332-4347.
23. Sheikh KA, Sun J, Lui Y, Kawai H, Crawford TO, et al. (1999) Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects. Proc Natl Acad Sci U S A 96: 7532-7537. (Pubitemid 29299696)
24. Zhang G, Lehmann HC, Bogdanova N, Gao T, Zhang J, et al. (2011) Erythropoietin enhances nerve repair in anti-ganglioside antibody-mediated models of immune neuropathy. PLoS One 6: e27067.
25. Letourneur O, Kennedy IC, Brini AT, Ortaldo JR, O'Shea JJ, et al. (1991) Characterization of the family of dimers associated with Fc receptors (Fc epsilon RI and Fc gamma RIII). J Immunol 147: 2652-2656.
26. Goodfellow JA, Bowes T, Sheikh K, Odaka M, Halstead SK, et al. (2005) Overexpression of GD1a ganglioside sensitizes motor nerve terminals to anti-GD1a antibody-mediated injury in a model of acute motor axonal neuropathy. J Neurosci 25: 1620-1628. (Pubitemid 40279266)
27. Vass K, Hickey WF, Schmidt RE, Lassmann H (1993) Bone marrow-derived elements in the peripheral nervous system. An immunohistochemical and ultrastructural investigation in chimeric rats. Lab Invest 69: 275-282. (Pubitemid 23315711)
28. Mueller M, Leonhard C, Wacker K, Ringelstein EB, Okabe M, et al. (2003) Macrophage response to peripheral nerve injury: the quantitative contribution of resident and hematogenous macrophages. Lab Invest 83: 175-185. (Pubitemid 36255363)
29. Takai T, Li M, Sylvestre D, Clynes R, Ravetch JV (1994) FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell 76: 519-529. (Pubitemid 24064172)
30. Nimmerjahn F, Ravetch JV (2006) Fcgamma receptors: old friends and new family members. Immunity 24: 19-28. (Pubitemid 43077197)
31. Berry M, Carlile J, Hunter A (1996) Peripheral nerve explants grafted into the vitreous body of the eye promote the regeneration of retinal ganglion cell axons severed in the optic nerve. J Neurocytol 25: 147-170. (Pubitemid 26098922)
32. Sahenk Z, Chen L, Mendell JR (1999) Effects of PMP22 duplication and deletions on the axonal cytoskeleton. Ann Neurol 45: 16-24. (Pubitemid 29036427)
33. Nimmerjahn F, Ravetch JV (2007) Fc-receptors as regulators of immunity. Adv Immunol 96: 179-204. (Pubitemid 350018720)
34. Nimmerjahn F, Bruhns P, Horiuchi K, Ravetch JV (2005) FcgammaRIV: a novel FcR with distinct IgG subclass specificity. Immunity 23: 41-51. (Pubitemid 41019656)
35. Ramon y Cajal, S. (1928) Degeneration and regeneration of the nervous system (R.M. May, Trans.). London: Oxford University Press.
36. Vedeler CA, Conti G, Bannerman P, Pleasure D (1992) Expression of genes encoding receptors for IgG (FcRIII) and for C3b/C4b (Crry) in rat sciatic nerve during development and Wallerian degeneration. J Neurosci Res 31: 654-661.
37. Nyland H, Matre R, Mork S (1980) Fc receptors of microglial lipophages in multiple sclerosis. N Engl J Med 302: 120-121.
38. Halstead SK, Humphreys PD, Goodfellow JA, Wagner ER, Smith RA, et al. (2005) Complement inhibition abrogates nerve terminal injury in Miller Fisher syndrome. Ann Neurol 58: 203-210. (Pubitemid 41098878)
39. Halstead SK, Zitman FM, Humphreys PD, Greenshields K, Verschuuren JJ, et al. (2008) Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model. Brain 131: 1197-1208.
40. Halstead SK, Humphreys PD, Zitman FM, Hamer J, Plomp JJ, et al. (2008) C5 inhibitor rEV576 protects against neural injury in an in vitro mouse model of Miller Fisher syndrome. J Peripher Nerv Syst 13: 228-235.
41. Goodyear CS, O'Hanlon GM, Plomp JJ, Wagner ER, Morrison I, et al. (1999) Monoclonal antibodies raised against Guillain-Barre syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations. J Clin Invest 104: 697-708. (Pubitemid 29536355)
42. van Sorge NM, van der Pol WL, Jansen MD, Geleijns KP, Kalmijn S, et al. (2005) Severity of Guillain-Barre syndrome is associated with Fc gamma Receptor III polymorphisms. J Neuroimmunol 162: 157-164.
43. van der Pol WL, van den Berg LH, Scheepers RH, van der Bom JG, Van Doorn PA, et al. (2000) IgG receptor IIa alleles determine susceptibility and severity of Guillain-Barre syndrome. Neurology 54: 1661-1665. (Pubitemid 30226812)
44. Schwartz M, Sela BA, Eshhar N (1982) Antibodies to gangliosides and myelin autoantigens are produced in mice following sciatic nerve injury. J Neurochem 38: 1192-1195. (Pubitemid 12091475)
45. Zhang Y, Popovich P (2011) Roles of autoantibodies in central nervous system injury. Discov Med 11: 395-402.
46. Hayes KC, Hull TC, Delaney GA, Potter PJ, Sequeira KA, et al. (2002) Elevated serum titers of proinflammatory cytokines and CNS autoantibodies in patients with chronic spinal cord injury. J Neurotrauma 19: 753-761. (Pubitemid 34761337)
47. Ulvestad E, Williams K, Vedeler C, Antel J, Nyland H, et al. (1994) Reactive microglia in multiple sclerosis lesions have an increased expression of receptors for the Fc part of IgG. J Neurol Sci 121: 125-131. (Pubitemid 24044876)
48. Ankeny DP, Guan Z, Popovich PG (2009) B cells produce pathogenic antibodies and impair recovery after spinal cord injury in mice. J Clin Invest 119: 2990-2999.
49. Ankeny DP, Popovich PG (2010) B cells and autoantibodies: complex roles in CNS injury. Trends Immunol 31: 332-338.
50. Liu Y, Wada R, Kawai H, Sango K, Deng C, et al. (1999) A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder. J Clin Invest 103: 497-505. (Pubitemid 29094050)
51. Kawai H, Allende ML, Wada R, Kono M, Sango K, et al. (2001) Mice expressing only monosialoganglioside GM3 exhibit lethal audiogenic seizures. J Biol Chem 276: 6885-6888.